A study of U.S., British and German diabetes patients found 44 percent say the disease affects their ability or desire to have sex, researchers said.
Submitted by Amy Tenderich
Medingo US, Inc. introduced a brand new miniature, tube-free insulin delivery system, the Solo MicroPump, at the American Association of Diabetes Educators Meeting in Atlanta, GA, August 5-8, 2009.
Submitted by Amy Tenderich
Certain blood-glucose test strips called GDH-PQQ strips, maybe inaccurate when it comes to measuring blood sugar levels, leading to patients receiving inaccurate information that could then result in them acting inappropriately relating to giving insulin shots.
Submitted by Amy Tenderich
Judge Sonia Sotomayor succeeds with (or despite) her diabetes.
Submitted by Amy Tenderich
Judge Sonia Sotomayor succeeds with (or despite) her diabetes.
Submitted by Amy Tenderich
Last week, a team of eight cyclists completed the coast-to-coast bike marathon called the Race Across America in record time. It was quite an achievement under any circumstances, but what made it extraordinary was something all eight of them had in common: Type 1 diabetes.
Submitted by Amy Tenderich
Vegan Diet May Treat Diabetes:
Study Shows It Might Help Reduce Need To Take Medications For Type 2 Diabetes
Submitted by Auberginecow
Many types of diabetes pills can help people with type 2 diabetes lower their blood glucose. Each class of pill helps lower blood glucose in a different way. You might know your pill (or pills) by a different name.
Each of the medicines discussed here has side effects and other warnings and precautions. Some diabetes pills have been associated with increased risk of heart disease. It is important to discuss the risks and benefits... read more
Submitted by lipsie
A new once-weekly form of injectable diabetes drug Byetta (still awaiting FDA approval) proved superior to the widely used medicines Actos and Januvia in a clinical trial, according to data presented on Saturday.
Submitted by Amy Tenderich
For more than a decade, MannKind Corp. of Valencia, Calif., has sunk about $1 billion into developing a fast-acting inhaled insulin, touting it as easier to take than frequent injections and medically superior to traditional medicines for controlling blood sugar.
Submitted by Amy Tenderich